The product from BioCell Technology is specially formulated with BioCell type II collagen
BioCell Technology has announced that its flagship healthy ageing ingredient, BioCell Collagen, is featured in a new product launch from the Bluebonnet targeted choice product line, Joint Support.
Targeted choice Joint Support Caplets are specially formulated with BioCell type II collagen and identity-preserved (IP) vitamin C, hyaluronic acid, glucosamine, chondroitin and MSM, as well as sustainably harvested or wildcrafted herbal extracts, such as turmeric root and white willow bark.
This wholesomely-crafted formula is designed to help optimise joint function by maintaining healthy cartilage, tendons and ligaments. Available in easy-to-swallow caplets for maximum assimilation and absorption.
“We are very excited to have BioCell Collagen featured in this fantastic formulation,” said Suhail Ishaq, President of BioCell Technology.
“Not only are we excited to reach a wider consumer base with the inclusion of BioCell Collagen in this product, but an offering Bluebonnet Targeted Choice Joint Support really showcases the power of BioCell Collagen’s utility for promoting an enhanced lifestyle with respect to joint comfort and mobility.”
“We are thrilled to incorporate such a quality raw material into our newest formulation for joint support. The science and clinical trials behind BioCell Collagen for joint comfort and mobility made it a no-brainer for us,” said Jennifer Weinhardt, R&D Specialist for Bluebonnet Nutrition.